OXR1 and nonpapillary renal cell carcinoma: In renal cell tumors (RCT), promoter methylation of HOX9A was disclosed in 73% of RCTs, and the two-gene (HOX9A and OXR1) methylation panel led to 90% sensitivity and 98% specificity in the identification of ccRCC (53).